Iranian Society of Gynecology Oncology
A Case of Misdiagnosed Gestational Trophoblastic Neoplasia with Brain and Lungs Metastasis; Complications and Modified Treatment: A Case Report

Shahrzad Sheikhhasani; Azamsadat Mousavi; Monireh Mirzai; Mitra Modares Gilani; Setareh Akhavan

Volume 3, Issue 2 , May and June 2018, , Pages 79-82

  Introduction: Timely diagnosis of gestational trophoblastic neoplasia (GTN) is essential for successful management of the condition and preservation of fertility. The aim of the present study was to describe a case of misdiagnosis GTN with brain and lungs metastasis. Patient information: The present ...  Read More

Recurrence and Fertility Rate in Females with Borderline Ovarian Tumor

Azamsadat Mousavi; Mahshid Shooshtari; Setare Nassiri; Abas Ali Aipour; Setare Akhavan; Narges Zamani

Volume 2, Issue 4 , November and December 2017, , Pages 1-5

  Background: Currently, the prevalence of borderline ovarian tumors (BOT) is increasing, and given the higher diagnosis in the third and fourth decades of life, fertility sparing procedures are widely used. There are important consequences in females with borderline ovarian tumors and number of effective ...  Read More

The Value of Ultrasonography in Predicting Invasive Mole

Setareh Akhavan; Azamsadat Mousavi; Mitra Modaresgilani; Abbas Alibakhshi; Maryam Rahmani; Nasrin Karimi

Volume 1, Issue 2 , September and October 2016

  Background: Gestational trophoblastic neoplasm (GTN) during pregnancy includes an associated heterogeneous group of lesions that originates from abnormal proliferation of placenta. It includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. Objectives: ...  Read More

Diagnosis and Management of Borderline Ovarian Tumor Based on the Iranian Guidelines

Setareh Akhavan; Azamsadat Mousavi; Abbas Alibakhshi

Volume 1, Issue 1 , May and June 2016

  Borderline ovarian tumors (BOT) consist of epithelial ovarian lesions that express cytological features of malignancy, but unlike malignant ovarian tumors, do not show obvious stromal invasion. The tumor incidence is between 1.8 and 4.8 per 100,000 females per year. The two major groups of BOT include ...  Read More